MRK Earnings: Highlights of Merck’s Q4 2023 financial results

Watch Icon
AlphaStreet
MRK Earnings: Highlights of Merck’s Q4 2023 financial results

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp fall in adjusted earnings for the fourth quarter of 2023, despite a modest increase in revenues.

Fourth-quarter worldwide sales increased 6% year-over-year to $14.6 billion, mainly reflecting the sustained growth across oncology and vaccines.

The company reported a net loss of $1.23 billion or $0.48 per share for the December quarter, compared to a profit of $3.02 billion or $1.18 per share in the prior-year period. On an adjusted basis, it was earnings of $0.03 per share in Q4, down 98% from the fourth quarter of 2022.

“As we move forward, I’m confident that our strong momentum will continue, underpinned by the unwavering dedication of our talented global team,” said Merck’s CEO Robert Davis.

Prior Performance

The post MRK Earnings: Highlights of Merck’s Q4 2023 financial results first appeared on AlphaStreet.

 

Default Featured Image

IDEXX Labs cut to Neutral at Piper Sandler | Investorempires.com

Read More | © Reuters. IDEXX Labs (IDXX) cut to Neutral at Piper Sandler – ‘Stock needs volume upside’ IDEXX Laboratories (IDXX) was downgraded to ‘Neutral’ from ‘Overweight’ with a price target of $525 at Piper Sandler on Tuesday due to softness in pet owner visits and wellness spending that could extend into 2025. Analysts […]

Grocery-delivery firm Instacart forecasts strong Q1, plans 250 job cuts By Reuters | Investorempires.com

Read More | © Reuters. Smartphone with displayed Instacart logo is seen in this illustration taken March 25, 2022. REUTERS/Dado Ruvic/Illustration (Reuters) -Instacart forecast on Tuesday its first-quarter gross transaction value and core profit above analysts’ estimates, and said it plans to cut 250 jobs, or about 7% of its workforce, to focus on “promising” […]